Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of the study is to compare the duration of analgesia in patients undergoing forearm or hand surgery with a supraclavicular brachial plexus block, who receive either iv dexmedetomidine or placebo.
Most surgical interventions on the forearm and the hand in Valais Hospital are performed under regional anesthesia. This ensures intraoperative patient comfort and reduces pain during the first 6 to 12 postoperative hours. A very common strategy to provide anesthesia of the arm is to inject local anesthetics in the region over the clavicle around the brachial plexus. This "supraclavicular brachial plexus block" is routinely performed in Valais Hospital and is always done under ultrasound guidance.
A drawback of locoregional anesthesia is the recurrence of pain once the effect of the block wears off after approximately 6 to 8 hours. This phenomenon is called rebound pain. It and can be very severe and debilitating, can significantly impact postoperative recovery and may also preclude ambulatory surgery as well as early mobilization and physiotherapy. Therefore, strategies that prolong the analgesic effect of locoregional anesthesia are warranted.
Dexmedetomidine is a selective α2-adrenoceptor agonists with sedative and analgesic properties. It has been shown to prolong the analgesic duration of local anesthetics when administered intravenously. However, the association of dexmedetomidine with long-acting local anesthetics for supraclavicular brachial plexus block has not been systematically investigated.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| intravenous dexmedetomidine | Active Comparator | Patients will receive intravenous dexmedetomidine 1 mcg/kg just after the supraclavicular brachial plexus block is completed |
|
| Placebo | Placebo Comparator | Patients will receive intravenous placebo (normal saline) just after the supraclavicular brachial plexus is completed |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexmedetomidine | Drug | After completion of supraclavicular brachial plexus block patients will receive intravenous dexmedetomidine 1 mcg/kg |
|
| Measure | Description | Time Frame |
|---|---|---|
| duration of analgesia | time in minutes from end of injection of local anesthetic till first analgesic request | 24 hours on day of surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of motor block | time in minutes from completion of locoregional anesthesia and the moment the patient can again mobilize the arm | 24 hours on day of surgery |
| Duration of sensory block |
Not provided
Inclusion Criteria:
Patients undergoing elbow, forearm or hand surgery under supraclavicular brachial plexus block Patients who are ASA physical status I-III
Exclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sina Grape, MD, MBA | Valais Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital du Valais | Sion | 1950 | Switzerland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41330797 | Derived | Grape S, Andany A, Cibotto C, Berri L, Rossel JB, Albrecht E. Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial. Br J Anaesth. 2026 May;136(5):1588-1594. doi: 10.1016/j.bja.2025.10.049. Epub 2025 Dec 1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Patients undergoing forearm or hand surgery under supraclavicular brachial plexus block, receiving either additional intravenous dexmedetomidine or placebo
Not provided
Not provided
dexmedetomidine or placebo prepared by Lausanne University Hospital Pharmacy
|
time in minutes from completion of locoregional anesthesia and the moment the patient regains sensation of the arm
| 24 hours on day of surgery |
| Pain scores at rest | Pain scores at rest on numeric scale, 0=no pain at all to 10=worst pain imaginable | 4, 24, 48 hours postoperatively |
| Pain scores on movement | Pain scores on movement, on numeric scale, 0=no pain at all to 10=worst pain imaginable | 4, 24, 48 hours postoperatively |
| Cumulative amount of opiate analgesic medication consumed | in intravenous morphine equivalents (mg) | 24, 48 hours postoperatively |
| Patient satisfaction | on 4 point Likert scale: dissatisfied / neutral / satisfied / extremely satisfied | 7 days postoperatively |
| Total number of dexmedetomidine-related side effects | Total number of dexmedetomidine-related side effects, in particular bradycardia and hypotension | 24 hours postoperatively |
| Dexmedetomidine-related side effects | Number and % of patients who experience at least one dexmedetomidine-related side effect | 24 hours postoperatively |
| Opioid-related side effect | Number and % of patients who experience at least one opioid-related side effect | 24 hours postoperatively |